Press Releases

Press Releases

February 24, 2021
Establishment Labs Announces Raj Denhoy Has Joined the Company as Head of Strategy and Investor Relations
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Feb. 24, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that Raj Denhoy has been appointed Head of Strategy and
February 24, 2021
Establishment Labs to Announce Fourth Quarter 2020 Financial Results on March 10
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Feb. 24, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended December 31,
February 16, 2021
Establishment Labs Announces Participation in the Cowen 41st Annual Healthcare Conference
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Feb. 16, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief
February 9, 2021
Establishment Labs Hosts Investor Event for its Motiva MIA® System for Minimally Invasive Augmentation
Minimally Invasive creates a new product category in breast aesthetics with a total addressable market of $4-5 billion Clinical study shows significant benefits compared to traditional breast augmentation surgery, with procedures performed without general anesthesia and women experiencing faster
February 3, 2021
Establishment Labs Announces Participation in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Feb. 3, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief
January 21, 2021
Establishment Labs to Host Investor Event Featuring Its Motiva Mia System
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Jan. 21, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it will host a virtual investor event on Feb.
January 13, 2021
Establishment Labs Announces Participation in the 39th Annual J.P. Morgan Healthcare Conference
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Jan. 13, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós will
January 11, 2021
Establishment Labs Reports Preliminary Results for Fourth Quarter and Fiscal Year 2020
Preliminary Revenue of $26.5 million to $27.5 million for the 4 th Quarter, and $84.2 million to $85.2 million for Fiscal Year 2020 Strong Performance Throughout Europe and Rebound to Pre-Pandemic Levels in Latin America Drive Record Quarterly Sales Cash Balance at December 31, 2020 an Estimated